<b>Conclusions:</b> DBT potentiates PTX efficacy in NSCLC by disrupting the Nrf2/GPX4 axis to induce ferroptosis while mitigating chemotherapy-related toxicity, supporting its potential as an adjuvant strategy targeting oxidative stress pathways. The gene discussed is GPX4; the disease is non-small cell lung carcinoma.